Lindholm E M, Bielicki J K, Curtiss L K, Rubin E M, Forte T M
Department of Molecular and Nuclear Medicine, Life Sciences Division MS 1-220, Lawrence Berkeley National Laboratory, University of California, Berkeley, California 94720, USA.
Biochemistry. 1998 Apr 7;37(14):4863-8. doi: 10.1021/bi972888i.
Human apolipoprotein A-I (apoA-I) has an important role in the efflux of cholesterol from peripheral cells, the first step in reverse cholesterol transport. Deletion of amino acids Glu146-->Arg160 in apoA-I (apoA-ISeattle) removes a large section of a lipid binding helix and is associated in vivo with an atherogenic lipoprotein profile characterized by a deficiency in high-density lipoproteins (HDL). In the present study, we asked whether apoA-ISeattle had normal ability to recruit lipids from cells and to form nascent high-density lipoprotein (HDL) particles and whether the altered secondary structure affected lecithin:cholesterol acyltransferase (LCAT) activity. Wild-type apoA-I and apoA-ISeattle expressed in transfected Chinese hamster ovary cells formed nascent HDL particles with similar density distribution and protein-to-lipid ratio. Phospholipid subclass distribution of apoA-ISeattle nascent HDL demonstrated a significant increase in sphingomyelin and phosphatidylethanolamine compared to wild type. ApoA-ISeattle nascent HDL had a unique size distribution compared to wild-type nascent HDL; large (9-20 nm) particles predominated while there were virtually no small (7.5 nm) particles. LCAT reactivity was impaired by apoA-ISeattle nascent HDL where cholesterol esterification was only half that of wild-type complexes. The apoA-ISeattle conformation on nascent HDL was studied with a panel of monoclonal antibodies (Mabs) specific for apoA-I. Mabs that recognize the putative LCAT activation site, residues 95-122, had normal reactivity. As expected, the Mabs that recognized residues 141-164 were unreactive because of the 146-160 deletion; in addition, there was low reactivity with a Mab that recognizes residues 220-242. The data suggest that apoA-I residues 146-160 and/or 220-242 partake in normal LCAT activation and that cooperative interactions between helices may be important for maximal cholesterol esterification.
人载脂蛋白A-I(apoA-I)在胆固醇从外周细胞流出过程中发挥重要作用,这是逆向胆固醇转运的第一步。apoA-I中氨基酸Glu146→Arg160的缺失(apoA-西雅图突变体)去除了一大段脂质结合螺旋结构,并且在体内与以高密度脂蛋白(HDL)缺乏为特征的致动脉粥样硬化脂蛋白谱相关。在本研究中,我们探究了apoA-西雅图突变体是否具有从细胞募集脂质并形成新生高密度脂蛋白(HDL)颗粒的正常能力,以及二级结构的改变是否会影响卵磷脂胆固醇酰基转移酶(LCAT)的活性。在转染的中国仓鼠卵巢细胞中表达的野生型apoA-I和apoA-西雅图突变体形成了具有相似密度分布和蛋白质与脂质比率的新生HDL颗粒。与野生型相比,apoA-西雅图突变体新生HDL的磷脂亚类分布显示鞘磷脂和磷脂酰乙醇胺显著增加。与野生型新生HDL相比,apoA-西雅图突变体新生HDL具有独特的大小分布;大颗粒(9 - 20纳米)占主导,而几乎没有小颗粒(7.5纳米)。apoA-西雅图突变体新生HDL的LCAT反应性受损,其胆固醇酯化仅为野生型复合物的一半。使用一组针对apoA-I的单克隆抗体(Mab)研究了新生HDL上的apoA-西雅图突变体构象。识别假定的LCAT激活位点(残基95 - 122)的Mab具有正常反应性。正如预期的那样,识别残基141 - 164的Mab由于146 - 160缺失而无反应;此外,与识别残基220 - 242的Mab反应性较低。数据表明,apoA-I残基146 - 160和/或220 - 242参与正常的LCAT激活,并且螺旋之间的协同相互作用对于最大程度的胆固醇酯化可能很重要。